Advisor Group Holdings, Inc. Infinity Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $295 - $850	-500 Reduced 26.82%	1,364 $1,000
Q3 2021 Nov 05, 2021	BUY	$1.52 - $3.82 $1,520 - $3,820	1,000 Added 115.74%	1,864 $6,000
Q1 2021 May 13, 2021	BUY	$1.98 - $5.36 $990 - $2,680	500 Added 137.36%	864 $3,000
Q4 2020 Feb 10, 2021	SELL	$1.05 - $2.77 $14,502 - $38,259	-13,812 Reduced 97.43%	364 $1,000
Q1 2020 May 18, 2020	BUY	$0.69 - $1.52 $9,781 - $21,547	14,176 New	14,176 $12,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.